key: cord-0691040-gu6m3goi authors: Schapkaitz, Elise; De Jager, Tanya; Levy, Brian title: The characteristic peripheral blood morphological features of hospitalized patients infected with COVID‐19 date: 2020-12-03 journal: Int J Lab Hematol DOI: 10.1111/ijlh.13417 sha: 95e71e82f47a359de5277d4ac9421080e61f7f67 doc_id: 691040 cord_uid: gu6m3goi nan Dear Editor, Furthermore, the cytokine storm associated with COVID-19 is responsible for activation of coagulation. In conjunction with hypoxia, inflammation and upregulated tissue factor expression contribute to pulmonary microvascular thrombosis associated with severe infection. 10 In the current study, platelet counts and d-dimer levels of ICU admissions were significantly elevated (P < .041 and P < .009, respectively). Similarly, other studies have reported that the d-dimer is the strongest independent predictor of mortality in COVID-19 patients. 11 In addition to a thrombocytosis, a subsequent increased mean platelet volume (MPV) and higher platelet-to-lymphocyte ratio (PLR) have also been reported in association with severe infection. 12 The MPV and PLR represent accessible, efficient and cost-effective surrogate markers of platelet activation, and systemic inflammation in severe infection. Nonetheless, in this study, although a higher MPV and PLR were observed among ICU admissions, this did not achieve statistical significance. The MPV and PLR require further evaluation in a prospective multi-center study in order to determine their use for risk stratification and clinical decision-making in a resource-limited setting. The findings of this study must be interpreted in light of certain limitations. First, this was a single-center study which is a specialist facility. As such, the study patients represent a highly selective group from the total pool of COVID-19 infections in South Africa. A second limitation of this study is as a result of limited resources, only patients with severe COVID-19 pneumonia were hospitalized during the study period. Thirdly, we acknowledge that therapies administered, for example, steroids could potentially influence our results. Lastly, a large proportion of patients were still admitted at the time of this report. As such mortality and discharge outcomes could not be reported. In conclusion, we have described how the characteristic peripheral blood findings of COVID-19 infection can be used to assess the extent of the viral effects, immune dysregulation and systemic inflammation of COVID-19. We thank the laboratory staff at CMJAH for their bravery in the fight against SARS-CoV-2 and their efforts toward saving lives. We thank RC Janet for proofreading the manuscript. The author(s) declare no conflict of interests with respect to the authorship and/or publication of this article. As co-first authors, ES and TD contributed equally to study design, data collection, entry and analysis and writing of the manuscript. BL contributed to study design and critical review of the manuscript. All authors revised the manuscript and approved the final version. Elise Schapkaitz 1 Hematologic parameters in patients with COVID-19 infection Clinical features of patients infected with 2019 novel coronavirus in Wuhan Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells Morphological anomalies of circulating blood cells in COVID-19 Reference Leukocyte (WBC) Differential Count (Proportional) and Evaluation of Instrumental Methods PA: CLSI Clinical characteristics of coronavirus disease 2019 in China Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 Coagulopathy in COVID-19 Pneumonia in Wuhan, China Use of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in COVID-19